Zepbound Explained — The New Weight Loss Drug - Who Gets the Shot? Eligibility & Access

from Zepbound Explained — The New Weight Loss Drug · host Inception Point AI

Julia Cartwright explores who qualifies for Zepbound, the GLP-1 weight loss medication showing 15-21% body weight reduction in trials. Learn FDA eligibility criteria, BMI thresholds, required comorbidities, and how to navigate the complex insurance prior authorization process that stands between patients and this transformative treatment option. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Episode metadata supplied by the publisher feed · Published Apr 7, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Zepbound Explained — The New Weight Loss Drug - Who Gets the Shot? Eligibility & Access

0:00 21:50

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Zepbound Explained — The New Weight Loss Drug?

This episode is 21 minutes long.

When was this Zepbound Explained — The New Weight Loss Drug episode published?

This episode was published on April 7, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Zepbound Explained — The New Weight Loss Drug episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!